Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids.

Carrigan CN, Patel SA, Cox HD, Bolstad ES, Gerdes JM, Smith WE, Bridges RJ, Thompson CM.

Bioorg Med Chem Lett. 2014 Feb 1;24(3):850-4. doi: 10.1016/j.bmcl.2013.12.086. Epub 2013 Dec 25.

2.

Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport.

Carrigan CN, Bartlett RD, Esslinger CS, Cybulski KA, Tongcharoensirikul P, Bridges RJ, Thompson CM.

J Med Chem. 2002 May 23;45(11):2260-76.

PMID:
12014964
3.

Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors.

Favre-Besse FC, Poirel O, Bersot T, Kim-Grellier E, Daumas S, El Mestikawy S, Acher FC, Pietrancosta N.

Eur J Med Chem. 2014 May 6;78:236-47. doi: 10.1016/j.ejmech.2014.03.056. Epub 2014 Mar 18.

PMID:
24686010
4.

Tetrapeptide inhibitors of the glutamate vesicular transporter (VGLUT).

Patel SA, Nagy JO, Bolstad ED, Gerdes JM, Thompson CM.

Bioorg Med Chem Lett. 2007 Sep 15;17(18):5125-8. Epub 2007 Jul 26.

5.

Inhibitor of the glutamate vesicular transporter (VGLUT).

Thompson CM, Davis E, Carrigan CN, Cox HD, Bridges RJ, Gerdes JM.

Curr Med Chem. 2005;12(18):2041-56. Review.

PMID:
16101493
6.

Quinoline-2,4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system.

Carrigan CN, Esslinger CS, Bartlett RD, Bridges RJ, Thompson CM.

Bioorg Med Chem Lett. 1999 Sep 6;9(17):2607-12.

PMID:
10498218
7.

Some new quinoline-based mono and dicarboxylic acids.

Ferranti A, Garuti L, Giovanninetti G, Roberti M, Varoli L.

Farmaco. 1993 Nov;48(11):1547-53.

PMID:
8110365
8.

Rose Bengal analogs and vesicular glutamate transporters (VGLUTs).

Pietrancosta N, Kessler A, Favre-Besse FC, Triballeau N, Quentin T, Giros B, El Mestikawy S, Acher FC.

Bioorg Med Chem. 2010 Sep 15;18(18):6922-33. doi: 10.1016/j.bmc.2010.06.069. Epub 2010 Jun 25.

PMID:
20708942
9.

Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles.

Bartlett RD, Esslinger CS, Thompson CM, Bridges RJ.

Neuropharmacology. 1998 Jul;37(7):839-46.

PMID:
9776380
10.

Synthesis of quinoline dicarboxylic esters as biocompatible fluorescent tags.

Laras Y, Hugues V, Chandrasekaran Y, Blanchard-Desce M, Acher FC, Pietrancosta N.

J Org Chem. 2012 Sep 21;77(18):8294-302. Epub 2012 Sep 12.

PMID:
22931204
11.

Use of the hydantoin isostere to produce inhibitors showing selectivity toward the vesicular glutamate transporter versus the obligate exchange transporter system x(c)(-).

Ahmed SK, Etoga JL, Patel SA, Bridges RJ, Thompson CM.

Bioorg Med Chem Lett. 2011 Jul 15;21(14):4358-62. doi: 10.1016/j.bmcl.2011.05.018. Epub 2011 May 14.

12.

Effects of glial glutamate transporter inhibitors on intracellular Na+ in mouse astrocytes.

Chatton JY, Shimamoto K, Magistretti PJ.

Brain Res. 2001 Mar 2;893(1-2):46-52.

PMID:
11222991
13.

Bovine neuronal vesicular glutamate transporter activity is inhibited by ergovaline and other ergopeptines.

Xue Y, Liao SF, Strickland JR, Boling JA, Matthews JC.

J Dairy Sci. 2011 Jul;94(7):3331-41. doi: 10.3168/jds.2010-3612.

PMID:
21700019
14.

A new VGLUT-specific potent inhibitor: pharmacophore of Brilliant Yellow.

Tamura Y, Ogita K, Ueda T.

Neurochem Res. 2014 Jan;39(1):117-28. doi: 10.1007/s11064-013-1196-8. Epub 2013 Nov 19.

15.

Synthesis and biological evaluation of nucleoside dicarboxylates as potential mimics of nucleoside diphosphates.

Boudreau MA, Vederas JC.

Org Biomol Chem. 2007 Feb 21;5(4):627-35. Epub 2007 Jan 18.

PMID:
17285171
16.

Spiro[2.2]pentane as a dissymmetric scaffold for conformationally constrained analogues of glutamic acid: focus on racemic 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids.

Pellicciari R, Marinozzi M, Camaioni E, del Carmen Nùnez M, Costantino G, Gasparini F, Giorgi G, Macchiarulo A, Subramanian N.

J Org Chem. 2002 Aug 9;67(16):5497-507.

PMID:
12153247
17.

Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid: a novel conformationally restricted glutamic acid analogue.

Bunch L, Liljefors T, Greenwood JR, Frydenvang K, Bräuner-Osborne H, Krogsgaard-Larsen P, Madsen U.

J Org Chem. 2003 Feb 21;68(4):1489-95.

PMID:
12585893
18.

Docking and homology modeling explain inhibition of the human vesicular glutamate transporters.

Almqvist J, Huang Y, Laaksonen A, Wang DN, Hovmöller S.

Protein Sci. 2007 Sep;16(9):1819-29. Epub 2007 Jul 27.

19.

Conformationally-restricted amino acid analogues bearing a distal sulfonic acid show selective inhibition of system x(c)(-) over the vesicular glutamate transporter.

Etoga JL, Ahmed SK, Patel S, Bridges RJ, Thompson CM.

Bioorg Med Chem Lett. 2010 Apr 15;20(8):2680-3. doi: 10.1016/j.bmcl.2009.10.020. Epub 2009 Oct 12.

20.

The antinociceptive effects of intracerebroventricular administration of Chicago sky blue 6B, a vesicular glutamate transporter inhibitor.

Yu G, Yi S, Wang M, Yan H, Yan L, Su R, Gong Z.

Behav Pharmacol. 2013 Dec;24(8):653-8. doi: 10.1097/FBP.0000000000000007.

PMID:
24128751

Supplemental Content

Support Center